Ignite Creation Date:
2024-05-06 @ 3:04 AM
Last Modification Date:
2024-10-26 @ 11:27 AM
Study NCT ID:
NCT02190123
Status:
COMPLETED
Last Update Posted:
2016-01-08
First Post:
2014-07-11
Brief Title:
REalWorld Insights on the INitiation and Treatment Duration of ticagrEloR Other Oral Antiplatelets OAP in Patients With Acute Coronary Syndrome ACS in BeLux
Sponsor:
Organization:
AstraZeneca
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
430
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Only |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 26543 |
Who Masked List: